BIO — BIO-RAD LABORATORIES, INC.
—
NYSE ·
Unknown ·
Unknown ·
CIK 12208 ·
Last close
$381.76
Market Cap
$8.28B
52W High
$385.92
52W Low
$270.00
ADV30
294,825
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 651,000,000 | 345,800,000 | 72,600,000 | 371,400,000 | 10,252,000,000 | 517,000,000 | 3,078,100,000 |
| Mar 2026 | 592,100,000 | 309,400,000 | 34,100,000 | -527,100,000 | 9,790,000,000 | 507,200,000 | 2,938,700,000 |
| Dec 2025 | 693,200,000 | 345,200,000 | 53,900,000 | 720,000,000 | 10,576,500,000 | 529,800,000 | 3,122,900,000 |
| Sep 2025 | 653,000,000 | 343,400,000 | 63,900,000 | -341,900,000 | 9,696,400,000 | 395,800,000 | 2,959,600,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$492,600,000
Investing CF
$-237,100,000
Financing CF
$-120,800,000
CapEx
$-139,500,000
Dividends Paid
—
Buybacks
$-132,700,000
EPS Diluted TTM
$8.25
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$8,020,600,000
Inventory
$780,600,000
Receivables
$441,800,000
ST Investments
$1,101,500,000
EBIT TTM
$399,200,000
Pretax Income TTM
$350,400,000
Interest Exp TTM
$48,800,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,589,299,968
EBITDA
$441,000,000
Free Cash Flow
$283,187,488
Enterprise Value
$9,959,465,984
Total Cash
$1,618,499,968
Total Debt
$1,370,400,000
Shares Out
21,700,560
Trailing EPS
$8.25
Book Value
$268.30
ROE
3.1%
ROA
1.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,583,200,000 | 218,600,000 | 759,900,000 | 10,576,500,000 | 3,122,900,000 | — | 532,200,000 |
| Dec 2024 | 2,566,500,000 | 269,000,000 | -1,844,200,000 | 9,364,100,000 | 2,794,800,000 | — | 455,200,000 |
| Dec 2023 | 2,671,200,000 | 337,800,000 | -637,300,000 | 12,299,100,000 | 3,557,900,000 | — | 374,900,000 |
| Dec 2022 | 2,802,200,000 | 475,100,000 | -3,627,500,000 | 13,501,666,000 | 3,886,414,000 | — | 194,400,000 |
TTM Snapshot
Revenues TTM
$2,563,648,000
NetIncome TTM
$1,518,914,000
OpCashFlow TTM
$0
Assets (Latest)
$9,364,100,000
Forward EPS
$10.03
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| STN | STANTEC INC | $8.34B | $74.21 | — |
| ACM | AECOM | $8.36B | $64.99 | — |
| MGCLY | Midea Group Co., Ltd./ADR | $8.16B | $12.54 | — |
| SSRM | SSR MINING INC. | $8.01B | $38.61 | — |
| ATR | APTARGROUP, INC. | $8.57B | $134.75 | — |
News headlines (Yahoo Finance, 1h cache)
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?
2026-08-20 15:23 · Yahoo
Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?
2026-08-14 00:13 · Yahoo
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript
2026-08-12 00:00 · Yahoo
Bio Rad Laboratories (BIO) Earnings And Guidance Put Fair Value Back In Focus
2026-08-09 22:16 · Yahoo
Bio-Rad Laboratories Q2 Earnings Call Highlights
2026-08-05 04:03 · Yahoo
Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates
2026-08-04 23:00 · Yahoo
Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026
2026-07-23 13:00 · Yahoo
Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock
2026-08-10 13:15 · Yahoo
Bio-Rad Laboratories, Inc. Q2 2026 Earnings Call Summary
2026-08-05 12:30 · Yahoo
Bio-Rad Reports Second-Quarter 2026 Financial Results
2026-08-04 20:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.